T1	SNP 0 16	Genetic variants
T2	Entity 20 25	COX-2
T3	Cancer 70 83	breast cancer
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T4	Association 84 88	risk
E1	Association:T4 bc:T3 snp_int:T1
T5	Therapeutic_response 517 538	inflammatory response
E3	Therapeutic_response:T5 Agent:T9
T8	Entity 555 560	NSAID
T7	Entity 418 434	cyclooxygenase-2
R2	Equiv Arg1:T2 Arg2:T7	
T9	SNP 444 461	genetic variation
T10	Entity 465 470	COX-2
R3	SNP_coupled_gene Arg1:T9 Arg2:T10	
T11	Spec 471 474	may
T12	Association 475 484	influence
E4	Association:T12 bc:T13 snp_int:T9
T13	Cancer 485 498	breast cancer
R4	Speculation_marker Arg1:E3 Arg2:T11	
T14	SNP 580 617	eight single nucleotide polymorphisms
T15	Entity 629 634	COX-2
R5	SNP_coupled_gene Arg1:T14 Arg2:T15	
T16	Spec 639 647	examined
T17	Association 654 665	association
E5	Association:T17 snp_int:T14 bc:T18
R6	Speculation_marker Arg1:E5 Arg2:T16	
T18	Cancer 679 692	breast cancer
T19	Entity 737 753	Western New York
R7	Population_assignment Arg1:T14 Arg2:T19	
T20	Entity 991 1020	adult lifetime use of aspirin
T21	Entity 1025 1048	recent use of ibuprofen
R8	Risk_Factor Arg1:T14 Arg2:T20	
R9	Risk_Factor Arg1:T14 Arg2:T21	
T6	SNP 1170 1179	rs2745559
R10	Member Arg1:T14 Arg2:T6	
T22	Association 1214 1218	risk
E2	Association:T22 snp_int:T6 bc:T24
T23	Effect_Type 1204 1213	increased
A1	Effect_Type E2 Increase
R11	Effect_type_marker Arg1:E2 Arg2:T23	
T24	Cancer 1222 1235	breast cancer
T25	SNP 1283 1297	other variants
T26	Neg 1303 1306	not
T27	Spec 1307 1314	evident
T28	Association 1265 1277	Associations
E6	Association:T28 snp_int:T25 bc:T24
R12	Negation_marker Arg1:E6 Arg2:T26	
R13	Speculation_marker Arg1:E6 Arg2:T27	
R14	Member Arg1:T14 Arg2:T25	
T31	SNP 1394 1403	rs4648261
T32	Entity 1371 1389	recent aspirin use
T29	SNP 1423 1432	Variation
T33	Entity 1436 1441	COX-2
R16	SNP_coupled_gene Arg1:T29 Arg2:T33	
T34	Level 1446 1454	modestly
T35	Association 1455 1465	associated
E8	Association:T35 bc:T36 snp_int:T29
R17	Level_marker Arg1:E8 Arg2:T34	
T36	Cancer 1471 1484	breast cancer
T37	Spec 1555 1575	Better understanding
T38	SNP 1597 1614	genetic variation
T39	Entity 1591 1596	COX-2
R18	SNP_coupled_gene Arg1:T38 Arg2:T39	
T40	Therapeutic_response 1619 1630	interaction
E9	Therapeutic_response:T40 Agent:T38 Theme:T42
T41	Entity 1636 1641	NSAID
T42	Cancer 1649 1670	breast carcinogenesis
T43	Association 1583 1587	role
E10	Association:T43 bc:T42 snp_int:T38
R19	Speculation_marker Arg1:E10 Arg2:T37	
R20	Speculation_marker Arg1:E9 Arg2:T37	
T30	Level 1316 1327	Significant
T44	Therapeutic_response 1328 1339	interaction
E7	Therapeutic_response:T44 Agent:T31
R21	Level_marker Arg1:E7 Arg2:T30	
A2	Level E7 High
A3	SNP_Type T31 Non-Coding
R15	Member Arg1:T14 Arg2:T31	
R22	Equiv Arg1:T29 Arg2:T14	
R23	Equiv Arg1:T1 Arg2:T14	
R24	Risk_Factor Arg1:T9 Arg2:T8	
R25	Risk_Factor Arg1:T31 Arg2:T32	
R26	Risk_Factor Arg1:T38 Arg2:T41	
